| Literature DB >> 25548551 |
Shabbir Hussain1, Saqib Ali2, Saira Shahzadi2, Saroj K Sharma3, Kushal Qanungo3, Muhammad Shahid4.
Abstract
Organotin (IV) carboxylates with the general formulae R2Sn(Cl)L [R = Me (1), n-Bu (2), Ph (3)] and R3SnL [R = Me (4), Ph (5)] have been synthesized by the reaction of 4-piperidinecarboxylic acid (HL) with KOH and R2SnCl2 (R = Me, n-Bu, Ph)/R3SnCl (R = Me, Ph) in methanol under stirring conditions. The metal ligand binding site, structure, and stability of complexes have been verified by FT-IR, ((1)H, (13)C) NMR, EI-MS technique, and semiempirical study. The FT-IR data indicate the bidentate chelating mode of the carboxylate ligand which is also confirmed by semiempirical study. In solution state, five and four coordinated geometry around tin was confirmed by NMR spectroscopy. The EI-MS data agreed well with the molecular structure of the complexes. Thermodynamic parameters and molecular descriptors were calculated by using semiempirical PM3 method. HOMO-LUMO calculations show that chlorodiorganotin complexes are more susceptible to nucleophilic attack as compared to triorganotin complexes. Computed negative heat of formation indicates that complexes 1-4 are thermodynamically stable. The organotin(IV) carboxylates displayed powerful antimicrobial activities against various strains of bacteria and fungi and their minimal inhibitory concentration were also evaluated. The complexes exhibited comparatively higher hemolytic activity as compared to free ligand.Entities:
Year: 2014 PMID: 25548551 PMCID: PMC4274932 DOI: 10.1155/2014/959203
Source DB: PubMed Journal: Bioinorg Chem Appl Impact factor: 7.778
Figure 5Physical data of organotin complexes 1–5.
| Comp. number | Molecular formula | Mol. Wt | Yield (%) | m.p (°C) | Elemental analysis Calcd. (found) | ||
|---|---|---|---|---|---|---|---|
| %C | %H | %N | |||||
|
| C6H11NO2 | 129.16 | — | 300 | — | — | — |
|
| C8H16NO2SnCl | 312.38 | 84 | 220 | 30.73 (30.77) | 5.12 (5.16) | 4.48 (4.44) |
|
| C14H28NO2SnCl | 396.54 | 84 | 233 | 42.36 (42.41) | 7.06 (7.02) | 3.53 (3.57) |
|
| C18H20NO2SnCl | 436.52 | 82 | 272 | 49.48 (49.52) | 4.58 (4.62) | 3.20 (3.24) |
|
| C9H19NO2Sn | 291.96 | 85 | 261 | 36.99 (36.95) | 6.50 (6.54) | 4.79 (4.83) |
|
| C24H25NO2Sn | 478.17 | 81 | 245 | 60.22 (60.26) | 5.22 (5.26) | 2.92 (2.96) |
IR dataa (cm−1) of organotin(IV) complexes 1–5.
| Comp. number |
|
|
| Δ |
|
|
| |
|---|---|---|---|---|---|---|---|---|
| asym | sym | |||||||
|
| 3639 b | 3456b | 1671w | 1398s | 273 | — | — | — |
|
| — | 3459m | 1622s | 1438s | 184 | 543b | 450m | 375s |
|
| — | 3457b | 1629s | 1483m | 146 | 519w | 449w | 328s |
|
| — | 3461b | 1606s | 1452w | 154 | 279s | 442b | 318b |
|
| — | 3462b | 1601s | 1441w | 161 | 554s | 451m | — |
|
| — | 3456b | 1551s | 1370m | 181 | 264s | 447m | — |
as: strong; m: medium; w: weak; b: broad.
1H NMR dataa of organotin complexes 1–5.
| Proton number | Chemical shift (ppm) | ||||||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| ||
|
| 1 | 2.32–2.41m | 2.74–2.81m | 2.90–2.96m | 2.61–2.65m | 2.36–2.43m | 2.73–2.81m |
| 2, 2′(a) | 1.83–1.89m | 1.82–1.98m | 1.86–1.90m | 1.85–1.93m | 1.78–1.88m | 1.80–1.97m | |
| 2, 2′(e) | 2.12–2.17m | 2.11–2.19m | 2.11–2.18m | 2.12–2.17m | 2.05–2.11m | 2.08–2.21m | |
| 3, 3′(a) | 2.74–2.79m | 3.05–3.13m | 2.88–2.92m | 3.07–3.12m | 2.97–3.05m | 3.01–3.13m | |
| 3, 3′(e) | 3.23–3.35m | 3.36–3.41m | 3.15–3.22m | 3.35–3.38m | 3.32–3.35m | 3.35–3.43m | |
| 4 | 2.50s | 2.58s | 2.52s | 2.57s | 2.59s | 2.58s | |
|
| |||||||
| Sn–R |
| 0.78s [90] | 1.19–1.37m | — | 0.4s [52] | — | |
|
| — | 1.59–1.61m | 7.85–7.89m | — | 7.81–7.88m | ||
|
| — | 1.40–1.56m | 7.35–7.49m | — | 7.42–7.52m | ||
|
| — | 0.89t (7.2) | 7.51–7.59m | — | 7.50–7.62m | ||
a J[119Sn, 1H] and J(1H, 1H) are listed in square brackets and parenthesis, respectively; multiplicity is given as s: singlet, t: triplet, and m: multiplet.
See Scheme 1.
(C–Sn–C) angles (°) based on NMR parameters.
| Comp. number |
2
| Angle, |
|---|---|---|
|
| 90.0 | 135.5 |
|
| 52 | 109.2 |
13C NMR dataa of organotin complexes 1–5.
| Carbon number | Chemical shift (ppm) | ||||||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| ||
|
| 1 | 178.2 | 179.5 | 179.1 | 179.6 | 179.8 | 179.7 |
| 2 | 42.6 | 42.1 | 42.8 | 42.4 | 42.6 | 42.8 | |
| 3, 3′ | 24.2 | 27.3 | 27.7 | 27.2 | 27.9 | 27.2 | |
| 4, 4′ | 51.1 | 51.3 | 51.6 | 51.5 | 51.8 | 51.2 | |
|
| |||||||
| Sn–R |
| — | 24.6 [593.1, 567.3] | 25.7 [541.1, 516.3] | 135.2 [56.4] | −2.0 [395.6] | 138.06 [583.1, 557.3] |
|
| — | — | 27.7 [39.0] | 141.2 | 128.99 [61.4, 59.0] | ||
|
| — | — | 26.2 [117.3, 112.6] | 129.1 [88.2] | 136.57 [44.3] | ||
|
| — | — | 14.2 | 130.2 [56.6] | 129.94 [12.5] | ||
aChemical shifts (δ) in ppm. J[119/117Sn, 13C] in Hz is listed in square brackets.
See Scheme 1.
Mass spectral data of organotin complexes 2, 3, and 5.
| Comp. number |
|
|---|---|
|
| [C14H28NO2SnCl]+ 397 (n.o)#, [C8H18ClSn]+ 269 (3), [C6H9NO2Sn]+ 247 (9), [C4H9ClSn]+ 212 (8), [C4H9Sn]+ 177 (2), [HO2Sn]+ 153 (12), [C6H10NO2]+ 128 (3), [Sn]+ 120 (2), [C5H8N]+ 82 (3), [C4H9]+ 57 (100). |
|
| |
|
| [C18H20NO2SnCl]+ 437 (n.o)#, [C12H15ClNOSn]+ 344 (1), [C12H10ClSn]+ 309 (1), [C6H10ClNOSn]+ 267 (3), [C6H8ClNOSn]+ 265 (2), [C6H5ClSn]+ 232 (3), [C6H5Sn]+ 197 (3), [C12H10]+ 154 (9), [C6H10NO2]+ 128 (14), [C6H10NO]+ 112 (3), [C6H6]+ 78 (100), [C6H5]+ 77 (35), [C3HN]+ 51 (56). |
|
| |
|
| [C24H25NO2Sn]+ 479 (26)#, [C24H25NO2Sn]+ 480 (30), [C18H20NO2Sn]+ 402 (3), [C18H15Sn]+ 351 (77), [C12H15NO2Sn]+ 325 (1), [C12H10Sn]+ 274 (1), [C6H5Sn]+ 197 (1), [C12H10Sn]+ 128 (100), [Sn]+ 120 (1), [C6H10NO]+ 112 (23). |
#Molecular ion peak (M+); n.o: not observed.
Computed structural parameters of complexes 1–4.
| Comp. number |
|
|
|
|
|---|---|---|---|---|
| Sn–O bond lengths (Å) | 2.02, 2.61 | 2.02, 2.66 | 2.00, 2.65 | 2.03, 2.73 |
| Sn–C bond lengths (Å) | 2.08, 2.08 | 2.12, 2.13 | 2.05, 2.05 | 2.10, 2.10, 2.11 |
| Sn–Cl bond length (Å) | 2.36 | 2.37 | 2.35 | — |
| O–Sn–O (°) | 51.8 | 50.9 | 51.1 | 49.3 |
| C–Sn–C (°) | 119.3 | 115.6 | 114.6 | 109.9, 109.9, 114.2 |
Computed thermodynamic parameters (at 298 K) of complexes 1–4.
| Comp. number |
|
|
|
|
|---|---|---|---|---|
| Heat of formation (KCal/mole) | −137.453 | −161.812 | −65.424 | −109.346 |
| Enthalpy (KCal/mole-K) | 9.308 | 11.340 | 11.000 | 9.608 |
| Entropy (KCal/mole-K) | 0.117 | 0.130 | 0.128 | 0.118 |
| Heat capacity (Cp) (Cal/mole-K) | 54.555 | 72.716 | 71.764 | 57.727 |
Figure 1(a) HOMO of complex 1; (b) LUMO of complex 1.
Figure 2(a) HOMO of complex 2; (b) LUMO of complex 2.
Figure 3(a) HOMO of complex 3; (b) LUMO of complex 3.
Figure 4(a) HOMO of complex 4; (b) LUMO of complex 4.
Computed molecular descriptors of complexes 1–4.
| Comp. number |
|
|
|
|
|---|---|---|---|---|
| HOMO energy (eV) | −9.582 | −9.527 | −9.510 | −9.408 |
| LUMO energy (eV) | −1.483 | −1.524 | −1.556 | −0.387 |
| HOMO-LUMO (eV) | 8.099 | 8.003 | 7.954 | 9.021 |
| Dipole moment (debye) | 3.282 | 4.509 | 4.477 | 1.668 |
| Global hardness ( | 4.049 | 4.001 | 3.977 | 4.510 |
| Global softness ( | 0.123 | 0.124 | 0.125 | 0.110 |
| Chemical potential ( | −5.532 | −5.525 | −5.533 | −4.897 |
| Electophilicity ( | 3.77 | 3.81 | 3.84 | 2.65 |
Antibacterial activity dataa, b of organotin complexes 1–5.
| Comp. number | Bacterial inhibition zone (mm) | |||
|---|---|---|---|---|
|
|
|
|
| |
|
| — | — | — | — |
|
| 30a ± 0.14 | 20bc ± 0.07 | 30ab ± 0.28 | 22b ± 0.20 |
|
| 26ab ± 0.22 | 25ab ± 0.19 | 30ab ± 0.21 | 28ab ± 0.31 |
|
| 28ab ± 0.30 | 20bc ± 0.14 | 30ab ± 0.29 | 27ab ± 0.14 |
|
| 14c ± 0.12 | 14c ± 0.15 | 16c ± 0.20 | 15c ± 0.11 |
|
| 21bc ± 0.13 | 19bc ± 0.07 | 23bc ± 0.12 | 25ab ± 0.22 |
| Streptomycin | 30a ± 0.17 | 31a ± 0.28 | 31ab ± 0.31 | 29a ± 0.28 |
aData are expressed as the mean ± standard deviation of samples analyzed individually in triplicate at P < 0.1.
bIt refers that how does bacterial inhibition zones are being calculated.
Antifungal activity dataa, b of organotin complexes 1–5.
| Comp. number | Fungal inhibition zone (mm) | ||||
|---|---|---|---|---|---|
|
|
|
|
|
| |
|
| — | — | — | — | — |
|
| 14c ± 0.15 | 21c ± 0.20 | 14c ± 0.11 | 13c ± 0.07 | 25c ± 0.23 |
|
| 20bc ± 0.19 | 22bc ± 0.13 | 19bc ± 0.08 | 18c ± 0.15 | 26bc ± 0.23 |
|
| 22bc ± 0.20 | 24bc ± 0.14 | 28bc ± 0.14 | 21ab ± 0.18 | 26bc ± 0.21 |
|
| 18bc ± 0.11 | 23bc ± 0.19 | 17bc ± 0.07 | 17bc ± 0.12 | 26bc ± 0.15 |
|
| 25bc ± 0.23 | 25bc ± 0.21 | 28bc ± 0.12 | 23a ± 0.20 | 28bc ± 0.23 |
| Fluconazole | 38a ± 0.29 | 41a ± 0.21 | 45a ± 0.31 | — | 37a ± 0.23 |
aData are expressed as the mean ± standard deviation of samples analyzed individually in triplicate at P < 0.1.
bIt refers that how does fungal inhibition zones are being calculated.
MIC (bacterial) of organotin complexes 1–5.
| Comp. number | Minimum inhibitory concentration ( | |||
|---|---|---|---|---|
|
|
|
|
| |
|
| — | — | — | — |
|
| 50 | 25 | 25 | — |
|
| 12.5 | 1.56 | 7.81 × 10−1 | 7.81 × 10−1 |
|
| 12.5 | 25 | 12.5 | 50 |
|
| 50 | — | 50 | — |
|
| 12.5 | 12.5 | 12.5 | 12.5 |
| Streptomycin | 9.7 × 10−2 | 1.95 × 10−1 | 6.25 | 3.12 |
MIC (fungal) of organotin complexes 1–5.
| Comp. number | Minimum inhibitory concentration ( | ||||
|---|---|---|---|---|---|
|
|
|
|
|
| |
|
| — | — | — | — | — |
|
| — | 6.25 | 25 | 7.81 × 10−1 | 3.12 |
|
| 1.56 | 7.81 × 10−1 | 7.81 × 10−1 | 3.90 × 10−1 | 7.81 × 10−1 |
|
| 7.81 × 10−1 | 1.95 × 10−1 | 1.95 × 10−1 | 9.76 × 10−2 | 3.12 |
|
| 12.5 | 3.12 | 12.5 | 7.81 × 10−1 | 3.12 |
|
| 9.76 × 10−2 | 3.12 | 2.44 × 10−2 | 2.44 × 10−2 | 3.90 × 10−1 |
| Fluconazole | 1.56 | 1.56 | 2.44 × 10−2 | 25 | — |
Hemolytic activity of organotin complexes 1–5.
| Comp. number | % of hemolysis |
|---|---|
|
| 8.70 ± 0.03 |
|
| 26.85 ± 0.05 |
|
| 14.42 ± 0.05 |
|
| 10.58 ± 0.08 |
|
| 24.02 ± 0.03 |
|
| 20.93 ± 0.06 |
| Triton X-100 | 99.53 ± 0.00 |